EFFECTIVE PROPHYLAXIS WITH BAY 94-9027 IN ADOLESCENTS WITH HEMOPHILIA A: RESULTS FROM THE PROTECT VIII MAIN STUDY AND ONGOING EXTENSION

被引：0
|
作者：
Kerlin, Bryce [1 ]
Ducore, Jonathan [1 ]
Ahuja, Sanjay [1 ]
Afonja, Olubunmi [1 ]
Saxena, Kapil [1 ]
机构：
[1] Bayer, Leverkusen, Germany
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
419
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effective protection for >5 years with bay 94-9027 prophylaxis: interim results from the protect VIII extension trial
    Thomson, G.
    Holme, P. A.
    Wang, M.
    Enriquez, M. Maas
    [J]. HAEMOPHILIA, 2018, 24 : 114 - 114
  • [2] BAY 94-9027 Provides Safe and Effective Long-Term Prophylaxis in Pediatric Patients: Results from the PROTECT VIII Kids Extension Study
    Ahuja, Sanjay
    Fischer, Kathelijn
    Biss, Tina
    Enriquez, Monika Maas
    Mancuso, Maria-Elisa
    Steele, MacGregor
    Wang, Maria
    Kenet, Gili
    [J]. BLOOD, 2020, 136
  • [3] BAY 94-9027 provides effective long-term prophylaxis in pediatric patients: Interim results of the PROTECT VIII Kids extension study
    Kenet, Gili
    Biss, Tina
    Steele, MacGregor
    Linardi, Camila
    Tseneklidou-Stoeter, Despina
    Saxena, Kapil
    [J]. HAEMOPHILIA, 2018, 24 : 15 - 15
  • [4] COMPARISON OF BLEEDING RATES BEFORE AND DURING BAY 94-9027 PROPHYLAXIS: DATA FROM THE PROTECT VIII STUDY AND EXTENSION
    Kerlin, Bryce A.
    Simpson, Mindy L.
    Reding, Mark T.
    Linardi, Camila
    Schwartz, Lawrence
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E32 - E32
  • [5] CONFIRMED SAFETY PROFILE OF BAY 94-9027 PROPHYLAXIS FOR ≥5 YEARS: OUTCOMES FROM THE PROTECT VIII AND PROTECT VIII KIDS EXTENSION STUDIES
    Mancuso, M. E.
    Holme, P. A.
    Kenet, G.
    Simpson, M.
    Di Minno, M. N. D.
    Baumann, A.
    Enriquez, Maas M.
    Reding, M. T.
    [J]. HAEMATOLOGICA, 2021, 106 (09) : 7 - 8
  • [6] BAY 94-9027 PROPHYLAXIS IMPROVES ACTIVITY AND WORK PRODUCTIVITY: DATA FROM THE PROTECT VIII STUDY
    Simpson, Mindy L.
    Lalezari, Shadan
    Chalasani, Pavani
    Tseneklidou-Stoeter, Despina
    Afonja, Olubunmi
    Enriquez, Monika Maas
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E60 - E60
  • [7] BAY 94-9027 is efficacious in maintaining hemostasis during major surgery in adults and adolescents with severe hemophilia A: protect VIII results
    Santagostino, E.
    Lalezari, S.
    Ducore, J.
    Michaels, L. A.
    Saxena, K.
    Linardi, C.
    [J]. HAEMOPHILIA, 2018, 24 : 69 - 69
  • [8] EFFICACY AND SAFETY OF BAY 94-9027 PROPHYLAXIS IS SUSTAINED FOR ≥ 6 YEARS: OUTCOMES IN 22 PATIENTS IN THE PROTECT VIII EXTENSION STUDY
    Mancuso, M. E.
    Klamroth, R.
    Miesbach, W.
    Holme, P. A.
    Enriquez, M. Maas
    Reding, M. T.
    [J]. HAEMOPHILIA, 2021, 27 : 64 - 65
  • [9] BAY 94-9027 prophylaxis improves quality of life: Haemo-QoL-A data from the PROTECT VIII study
    Linardi, Camila
    Enriquez, Monika Maas
    Lalezari, Shadan
    [J]. HAEMOPHILIA, 2018, 24 : 21 - 22
  • [10] PROTECT VIII Kids trial results: BAY 94-9027 safety and efficacy in previously treated children with severe hemophilia A
    Santagostino, Elena
    Saxena, Kapil
    Kenet, Gili
    Fischer, Kathelijn
    Biss, Tina
    Radke, Susan
    Michaels, Lisa A.
    [J]. HAEMOPHILIA, 2016, 22 : 41 - 41
12345